A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
The MIF SNP rs755622 is a germline determinant of tumor immune activation in Glioblastoma
[article]
2022
bioRxiv
pre-print
While immunotherapies have shown durable responses for multiple tumors, their efficacy remains limited in some advanced cancers, including glioblastoma. This may be due to differences in the immune landscape, as the glioblastoma microenvironment strongly favors immunosuppressive myeloid cells, which are linked to an elevation in immune-suppressive cytokines, including macrophage migration inhibitory factor (MIF). We now find that a single-nucleotide polymorphism (SNP) rs755622 in the MIF
doi:10.1101/2022.03.07.483365
fatcat:srwewpnrcbbanlkzxuhn2kgtaq